Schizopherenia.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Schizophrenia patient diagnosed by a psychiatrist Consent of the individual or his/her legal guardian to participate in the study. Breakfast or 250 cc of water. No heart problems. No use of blood pressure regulating medications. No acute or chronic sinusitis. No migraine headache. No anxiety. Adequate sleep of at least 6 hours the night before the intervention session. No alcohol, nicotine, and coffee consumption at least 24 hours before the study. Having normal binocular vision or 10/10. No drug abuse. No ECT treatment. The patient should only receive aripiprazole.
Exclusion criteria
Exclusion criteria: Headaches during the phase of decreasing cerebral cortex temperature Creating a state of anxiety during the phase of decreasing cerebral cortical temperature Nausea and dizziness during the phase of decreasing cerebral cortex temperature The individual can withdraw from the study at any time and for any reason.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sustained visual attention. Timepoint: The assessment of the sustained visual attention variable is performed before and after the frontal temperature reduction phase. Method of measurement: Using the Visual Search Test from the University of Cambridge's CANTAB test suite. | — |
Countries
Iran (Islamic Republic of)
Contacts
Yasouj University of Medical Sciences